Executive Solution Overview
See Attached – ## 5yearprojectiontemplateJohnsonJohnson.docx – ## JohnsonJohnsonCase_Financial_Statement_Template.xlsx **## 5yearprojectiontemplateJohnsonJohnson.docx** Five Year Projections- Johnson & Johnson Corporation Used this template on what needed for the 5 year projection. **Years: 2024 …
Instant Solution Download
$6.99Immediate access to the full model answer, formatted citations, and rubric breakdown.
Need a Fresh Custom Paper?
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Assignment Prompt & Instructions
See Attached
– ## 5yearprojectiontemplateJohnsonJohnson.docx
– ## JohnsonJohnsonCase_Financial_Statement_Template.xlsx
**## 5yearprojectiontemplateJohnsonJohnson.docx**
Five Year Projections- Johnson & Johnson Corporation
Used this template on what needed for the 5 year projection.
**Years: 2024 2025 2026 2027 2028**
**Income Statement**
**Net sales**
**Cost of goods sold**
**Net Operating Income**
**Operating expenses Net Income**
**Net Income**
**Cash Flow Statement**
**Beginning balance**
**Cash inflow $**
**Cash outflow**
**Ending Cash Balance $**
**Balance Sheet**
**Cash $**
**Accounts receivable $**
**Inventory**
**Prepaid expenses $**
**Total Current Assets $**
**Fixed assets $**
**Total Assets $**
**Accounts payable $**
**Short-term notes $**
**Accrued & other liabilities $**
**Total Current Liabilities $0**
**Long-term debt $**
**Other long-term liabilities $**
**Total Long-term Liabilities $**
**Shareholders' equity $**
**Total Liabilities and Equity $**
This worksheet estimates the key financial figures for a company over five years. The projections include abbreviated income and
**## JohnsonJohnsonCase_Financial_Statement_Template.xlsx**
## Company Financial Analysis
| | | | | | |
| — | — | — | — | — | — |
| Johnson & Johnson Case Financial Statement Template |
| (data in thousands [000s], excluding per share data and financial ratios) |
| | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Revenue |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit |
| Gross Profit Margin | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| EBIT |
| Income Tax |
| NOPAT (Net Operating Profit After Taxes) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income (includes discontinued operations) |
| Diluted Weighted Average Shares |
| Dividends per Share |
| Diluted Normalized EPS (continuing operations) |
| Cash Cycle | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Revenue per day | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts Receivable |
| Receivable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Inventory |
| Inventory Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Accounts Payable |
| Payable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Cash Cycle (days) | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Key Ratios | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Market Value of Book Equity |
| Price per share | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Earnings per share (continuing operations) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| P/E Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Invested Capital | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Assets | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Equity | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Assets |
| Current Assets |
| Current Liabilities |
| Current Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Debt |
| Debt/Equity Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Equity (book value) |
| Shareholders' Equity (minority interests) |
| Market to Book Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Per Employee | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Number of Employees (continuing operations) |
| Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Net Income | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Market Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
## Key Ratio Comparison
| | | | | |
| — | — | — | — | — |
| Competitor Financial Analysis |
| (data in thousands [000], excluding per share data and financial ratios) |
| FY Year | FY2023 | Ind Avg | Compet | Compet |
| Revenue | $0.00 |
| Cost of Revenue | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Margin | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| EBIT | $0.00 |
| Income Tax | $0.00 |
| NOPAT (Net Operating Profit After Taxes) | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income (includes discontinued operations) | $0.00 |
| Diluted Weighted Average Shares | – 0 |
| Dividends per Share | – 0 |
| Diluted Normalized EPS (continuing operations) | – 0 |
| Cash Cycle | FY2023 | Ind Avg | Compet | Compet |
| Revenue per day | – 0 |
| Accounts Receivable | – 0 |
| Receivable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Inventory | – 0 |
| Inventory Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Accounts Payable | – 0 |
| Payable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Cash Cycle (days) | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Key Ratios | FY2023 | Ind Avg | Compet | Compet |
| Market Value of Equity | $ – 0 |
| Price per share | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| P/E Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Invested Capital | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Assets | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Equity | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Assets | – 0 |
| Current Assets | – 0 |
| Current Liabilities | – 0 |
| Current Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Debt | – 0 |
| Debt/Equity Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Equity (book value) | – 0 |
| Shareholders' equity (minority interests) | – 0 |
| Market to Book Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Per Employee | FY2023 | Ind Avg | Compet | Compet |
| Number of Employees | – 0 |
| Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Net Income | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Market Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
**## JohnsonJohnsonCase_Financial_Statement_Template.xlsx**
## Company Financial Analysis
| | | | | | |
| — | — | — | — | — | — |
| Johnson & Johnson Case Financial Statement Template |
| (data in thousands [000s], excluding per share data and financial ratios) |
| | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Revenue |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit |
| Gross Profit Margin | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| EBIT |
| Income Tax |
| NOPAT (Net Operating Profit After Taxes) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income (includes discontinued operations) |
| Diluted Weighted Average Shares |
| Dividends per Share |
| Diluted Normalized EPS (continuing operations) |
| Cash Cycle | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Revenue per day | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts Receivable |
| Receivable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Inventory |
| Inventory Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Accounts Payable |
| Payable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Cash Cycle (days) | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Key Ratios | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Market Value of Book Equity |
| Price per share | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Earnings per share (continuing operations) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| P/E Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Invested Capital | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Assets | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Equity | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Assets |
| Current Assets |
| Current Liabilities |
| Current Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Debt |
| Debt/Equity Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Equity (book value) |
| Shareholders' Equity (minority interests) |
| Market to Book Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Per Employee | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Number of Employees (continuing operations) |
| Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Net Income | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Market Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
## Key Ratio Comparison
| | | | | |
| — | — | — | — | — |
| Competitor Financial Analysis |
| (data in thousands [000], excluding per share data and financial ratios) |
| FY Year | FY2023 | Ind Avg | Compet | Compet |
| Revenue | $0.00 |
| Cost of Revenue | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Margin | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| EBIT | $0.00 |
| Income Tax | $0.00 |
| NOPAT (Net Operating Profit After Taxes) | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income (includes discontinued operations) | $0.00 |
| Diluted Weighted Average Shares | – 0 |
| Dividends per Share | – 0 |
| Diluted Normalized EPS (continuing operations) | – 0 |
| Cash Cycle | FY2023 | Ind Avg | Compet | Compet |
| Revenue per day | – 0 |
| Accounts Receivable | – 0 |
| Receivable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Inventory | – 0 |
| Inventory Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Accounts Payable | – 0 |
| Payable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Cash Cycle (days) | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Key Ratios | FY2023 | Ind Avg | Compet | Compet |
| Market Value of Equity | $ – 0 |
| Price per share | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| P/E Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Invested Capital | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Assets | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Equity | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Assets | – 0 |
| Current Assets | – 0 |
| Current Liabilities | – 0 |
| Current Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Debt | – 0 |
| Debt/Equity Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Equity (book value) | – 0 |
| Shareholders' equity (minority interests) | – 0 |
| Market to Book Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Per Employee | FY2023 | Ind Avg | Compet | Compet |
| Number of Employees | – 0 |
| Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Net Income | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Market Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
**## 5yearprojectiontemplateJohnsonJohnson.docx**
Five Year Projections- Johnson & Johnson Corporation
Used this template on what needed for the 5 year projection.
**Years: 2024 2025 2026 2027 2028**
**Income Statement**
**Net sales**
**Cost of goods sold**
**Net Operating Income**
**Operating expenses Net Income**
**Net Income**
**Cash Flow Statement**
**Beginning balance**
**Cash inflow $**
**Cash outflow**
**Ending Cash Balance $**
**Balance Sheet**
**Cash $**
**Accounts receivable $**
**Inventory**
**Prepaid expenses $**
**Total Current Assets $**
**Fixed assets $**
**Total Assets $**
**Accounts payable $**
**Short-term notes $**
**Accrued & other liabilities $**
**Total Current Liabilities $0**
**Long-term debt $**
**Other long-term liabilities $**
**Total Long-term Liabilities $**
**Shareholders' equity $**
**Total Liabilities and Equity $**
This worksheet estimates the key financial figures for a company over five years. The projections include abbreviated income and
**## JohnsonJohnsonCase_Financial_Statement_Template.xlsx**
## Company Financial Analysis
| | | | | | |
| — | — | — | — | — | — |
| Johnson & Johnson Case Financial Statement Template |
| (data in thousands [000s], excluding per share data and financial ratios) |
| | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Revenue |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit |
| Gross Profit Margin | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| EBIT |
| Income Tax |
| NOPAT (Net Operating Profit After Taxes) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income (includes discontinued operations) |
| Diluted Weighted Average Shares |
| Dividends per Share |
| Diluted Normalized EPS (continuing operations) |
| Cash Cycle | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Revenue per day | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts Receivable |
| Receivable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Inventory |
| Inventory Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Accounts Payable |
| Payable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Cash Cycle (days) | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Key Ratios | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Market Value of Book Equity |
| Price per share | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Earnings per share (continuing operations) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| P/E Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Invested Capital | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Assets | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Equity | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Assets |
| Current Assets |
| Current Liabilities |
| Current Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Debt |
| Debt/Equity Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Equity (book value) |
| Shareholders' Equity (minority interests) |
| Market to Book Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Per Employee | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Number of Employees (continuing operations) |
| Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Net Income | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Market Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
## Key Ratio Comparison
| | | | | |
| — | — | — | — | — |
| Competitor Financial Analysis |
| (data in thousands [000], excluding per share data and financial ratios) |
| FY Year | FY2023 | Ind Avg | Compet | Compet |
| Revenue | $0.00 |
| Cost of Revenue | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Margin | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| EBIT | $0.00 |
| Income Tax | $0.00 |
| NOPAT (Net Operating Profit After Taxes) | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income (includes discontinued operations) | $0.00 |
| Diluted Weighted Average Shares | – 0 |
| Dividends per Share | – 0 |
| Diluted Normalized EPS (continuing operations) | – 0 |
| Cash Cycle | FY2023 | Ind Avg | Compet | Compet |
| Revenue per day | – 0 |
| Accounts Receivable | – 0 |
| Receivable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Inventory | – 0 |
| Inventory Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Accounts Payable | – 0 |
| Payable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Cash Cycle (days) | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Key Ratios | FY2023 | Ind Avg | Compet | Compet |
| Market Value of Equity | $ – 0 |
| Price per share | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| P/E Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Invested Capital | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Assets | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Equity | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Assets | – 0 |
| Current Assets | – 0 |
| Current Liabilities | – 0 |
| Current Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Debt | – 0 |
| Debt/Equity Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Equity (book value) | – 0 |
| Shareholders' equity (minority interests) | – 0 |
| Market to Book Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Per Employee | FY2023 | Ind Avg | Compet | Compet |
| Number of Employees | – 0 |
| Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Net Income | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Market Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
**## 5yearprojectiontemplateJohnsonJohnson.docx**
Five Year Projections- Johnson & Johnson Corporation
Used this template on what needed for the 5 year projection.
**Years: 2024 2025 2026 2027 2028**
**Income Statement**
**Net sales**
**Cost of goods sold**
**Net Operating Income**
**Operating expenses Net Income**
**Net Income**
**Cash Flow Statement**
**Beginning balance**
**Cash inflow $**
**Cash outflow**
**Ending Cash Balance $**
**Balance Sheet**
**Cash $**
**Accounts receivable $**
**Inventory**
**Prepaid expenses $**
**Total Current Assets $**
**Fixed assets $**
**Total Assets $**
**Accounts payable $**
**Short-term notes $**
**Accrued & other liabilities $**
**Total Current Liabilities $0**
**Long-term debt $**
**Other long-term liabilities $**
**Total Long-term Liabilities $**
**Shareholders' equity $**
**Total Liabilities and Equity $**
This worksheet estimates the key financial figures for a company over five years. The projections include abbreviated income and
**## JohnsonJohnsonCase_Financial_Statement_Template.xlsx**
## Company Financial Analysis
| | | | | | |
| — | — | — | — | — | — |
| Johnson & Johnson Case Financial Statement Template |
| (data in thousands [000s], excluding per share data and financial ratios) |
| | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Revenue |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit |
| Gross Profit Margin | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| EBIT |
| Income Tax |
| NOPAT (Net Operating Profit After Taxes) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income (includes discontinued operations) |
| Diluted Weighted Average Shares |
| Dividends per Share |
| Diluted Normalized EPS (continuing operations) |
| Cash Cycle | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Revenue per day | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts Receivable |
| Receivable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Inventory |
| Inventory Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Accounts Payable |
| Payable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Cash Cycle (days) | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Key Ratios | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Market Value of Book Equity |
| Price per share | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Earnings per share (continuing operations) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| P/E Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Invested Capital | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Assets | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Equity | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Assets |
| Current Assets |
| Current Liabilities |
| Current Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Debt |
| Debt/Equity Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Equity (book value) |
| Shareholders' Equity (minority interests) |
| Market to Book Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Per Employee | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Number of Employees (continuing operations) |
| Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Net Income | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Market Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
## Key Ratio Comparison
| | | | | |
| — | — | — | — | — |
| Competitor Financial Analysis |
| (data in thousands [000], excluding per share data and financial ratios) |
| FY Year | FY2023 | Ind Avg | Compet | Compet |
| Revenue | $0.00 |
| Cost of Revenue | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Margin | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| EBIT | $0.00 |
| Income Tax | $0.00 |
| NOPAT (Net Operating Profit After Taxes) | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income (includes discontinued operations) | $0.00 |
| Diluted Weighted Average Shares | – 0 |
| Dividends per Share | – 0 |
| Diluted Normalized EPS (continuing operations) | – 0 |
| Cash Cycle | FY2023 | Ind Avg | Compet | Compet |
| Revenue per day | – 0 |
| Accounts Receivable | – 0 |
| Receivable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Inventory | – 0 |
| Inventory Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Accounts Payable | – 0 |
| Payable Days | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Cash Cycle (days) | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Key Ratios | FY2023 | Ind Avg | Compet | Compet |
| Market Value of Equity | $ – 0 |
| Price per share | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| P/E Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Invested Capital | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Assets | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Equity | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Return on Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Assets | – 0 |
| Current Assets | – 0 |
| Current Liabilities | – 0 |
| Current Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Debt | – 0 |
| Debt/Equity Ratio | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Total Equity (book value) | – 0 |
| Shareholders' equity (minority interests) | – 0 |
| Market to Book Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Per Employee | FY2023 | Ind Avg | Compet | Compet |
| Number of Employees | – 0 |
| Revenue | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Net Income | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
| Market Value | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! | ERROR:#DIV/0! |
– 1
– 2
Leave a Reply